Lifevantage Corp LFVN revenue by segment, product and geography
In its fiscal year ending 2025-06-30, Lifevantage Corp reported revenue across 1 business segments; the largest, Reportable Segment, was $229M, 100.0% of the filed sum (+14.2% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Reportable Segment$229M100.0%+14.2% yoy
Members sum to the consolidated $229M for this period.
- Protandim$95.3M41.7%-8.5% yoy
- Life Vantage True Science Skin Care Regimen$56.2M24.6%+258.7% yoy
- True Science Product Line$48.7M21.3%-13.4% yoy
- AXIO Product Line$15.3M6.7%+14.5% yoy
- Product And Service Other$5.73M2.5%+27.4% yoy
- Phys IQ Product Line$5.1M2.2%+33.3% yoy
- Petandim Product Line$2.12M0.9%-11.7% yoy
Members sum to the consolidated $229M for this period.
- United States$178Mshare n/a+22.5% yoy
- Outside the United States$50.1Mshare n/a-8.1% yoy
- Japan$25.4Mshare n/a-5.9% yoy
- Other Foreign$24.7Mshare n/a-10.2% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Reportable Segment$43.7M100.0%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.